cometadata/datacite-titles-descriptions-related-identifiers huggingface dataset:
DOI: 10.6084/m9.figshare.12869909
title: supplimentary.xlsx

description: Supplementary data for study CCUS network generation for North-Central USA
DOI: 10.6084/m9.figshare.12869909.v1
title: supplimentary.xlsx

description: Supplementary data for study CCUS network generation for North-Central USA
DOI: 10.6084/m9.figshare.8845334
title: Supplementary Material for: Distribution of Human Papillomavirus Genotypes in Condylomata Acuminata: An Austrian Cohort Study

description: <b><i>Introduction:</i></b> Condylomata acuminata are caused by various genotypes of human papilloma viruses (HPV). <b><i>Methods:</i></b> We assessed the frequency of 33 different HPV DNA types in 49 patients with condylomata acuminata by the polymerase chain reaction technique. <b><i>Results:</i></b> Forty-two percent of the patients were infected with low-risk genotypes, and 21% of the patients tested positive for high-risk genotypes. Multiple infections with low- and high-risk genotypes were detectable in 36% of the patients. <b><i>Conclusion:</i></b> As our results are in line with previous large-scale reports, our data might serve as a basis for monitoring the efficacy of HPV vaccination in Austria.
DOI: 10.6084/m9.figshare.8845334.v1
title: Supplementary Material for: Distribution of Human Papillomavirus Genotypes in Condylomata Acuminata: An Austrian Cohort Study

description: <b><i>Introduction:</i></b> Condylomata acuminata are caused by various genotypes of human papilloma viruses (HPV). <b><i>Methods:</i></b> We assessed the frequency of 33 different HPV DNA types in 49 patients with condylomata acuminata by the polymerase chain reaction technique. <b><i>Results:</i></b> Forty-two percent of the patients were infected with low-risk genotypes, and 21% of the patients tested positive for high-risk genotypes. Multiple infections with low- and high-risk genotypes were detectable in 36% of the patients. <b><i>Conclusion:</i></b> As our results are in line with previous large-scale reports, our data might serve as a basis for monitoring the efficacy of HPV vaccination in Austria.
DOI: 10.6084/m9.figshare.8845304
title: Supplementary Material for: Mindfulness-Based Cognitive Therapy Intervention for the Treatment of Late-Life Depression and Anxiety Symptoms in Primary Care: A Randomized Controlled Trial

description: Medicine
DOI: 10.6084/m9.figshare.8845304.v1
title: Supplementary Material for: Mindfulness-Based Cognitive Therapy Intervention for the Treatment of Late-Life Depression and Anxiety Symptoms in Primary Care: A Randomized Controlled Trial

description: Medicine
DOI: 10.6084/m9.figshare.8845286
title: Supplementary Material for: Distinct Patterns of Hippocampal and Neocortical Evolution in Primates

description: Because of the central role of the hippocampus in representing spatial and temporal details of experience, comparative studies of its volume and structure are relevant to understanding the evolution of representational memory across species. The hippocampal formation, however, is organized into separate anatomical subregions with distinct functions, and little is known about the evolutionary diversification of these subregions. We investigate relative volumetric changes in hippocampal subregions across a large sample of primate species. We then compare the evolution of the hippocampal formation to the neocortex. Results across hippocampal subregions indicate that, compared to strepsirrhines, the anthropoid lineage displays a decrease in relative CA3, fascia dentata, subiculum, and rhinal cortex volume in tandem with an increase in relative neocortical volume. These findings indicate that hippocampal function in anthropoids might be substantially augmented by the executive decision-making functions of the neocortex. Humans are found to have a unique cerebral organization combining increased relative CA3, subiculum, and rhinal cortex with increased relative neocortical volumes, suggesting that these regions may play a role in behaviors that are uniquely specialized in humans.
DOI: 10.6084/m9.figshare.8845259
title: Raw Data - Estimation of iron content and its contribution in iron fortified food products consumed by school children in Sri Lanka.xlsx

description: The study was performed to quantify the concentration of iron in selected iron fortified foods available in Sri Lankan market and determine their contribution to the Recommended Daily Allowance per serving. To perform the experiment, six types of milk powder brands (iron fortified - A, B, C, D, E & non-iron fortified - F), two types of biscuits (iron fortified - G & non-iron fortified- H) and three types of breakfast cereals (iron fortified - I, J, K) were selected.<br><br>
DOI: 10.6084/m9.figshare.8845259.v1
title: Raw Data - Estimation of iron content and its contribution in iron fortified food products consumed by school children in Sri Lanka.xlsx

description: The study was performed to quantify the concentration of iron in selected iron fortified foods available in Sri Lankan market and determine their contribution to the Recommended Daily Allowance per serving. To perform the experiment, six types of milk powder brands (iron fortified - A, B, C, D, E & non-iron fortified - F), two types of biscuits (iron fortified - G & non-iron fortified- H) and three types of breakfast cereals (iron fortified - I, J, K) were selected.<br><br>
DOI: 10.6084/m9.figshare.8845229
title: AR-V7 expression in circulating tumor cells as a potential prognostic marker in metastatic hormone-sensitive prostate cancer

description: AR-V7 expression in circulating tumor cells as a potential prognostic marker in metastatic hormone-sensitive prostate cancer
DOI: 10.6084/m9.figshare.8845229.v1
title: AR-V7 expression in circulating tumor cells as a potential prognostic marker in metastatic hormone-sensitive prostate cancer

description: AR-V7 expression in circulating tumor cells as a potential prognostic marker in metastatic hormone-sensitive prostate cancer
DOI: 10.6084/m9.figshare.8845193
title: Survivors’ knowledge of their diagnosis, treatment and possible late adverse effects after autologous stem cell transplantation for lymphoma

description: <b>Purpose:</b> Lymphoma survivors after high dose therapy with autologous stem cell therapy (HD-ASCT) are at high risk for late adverse effects (AEs). Information patients receive and collect throughout their cancer trajectory about diagnosis, treatment schedule and risks of AEs may influence attitudes and health-related behavior in the years after treatment. The purpose of this study was to explore level of knowledge in lymphoma survivors after HD-ASCT at a median of 12 years after primary diagnosis. <b>Material and methods:</b> From a national study on the effects of HD-ASCT for lymphomas, 269 survivors met for an outpatient examination, including a structured interview addressing knowledge about diagnosis and treatment. Survivors were also asked whether they knew and/or had experienced certain common late AEs. Numbers of recognized and experienced late AEs were presented as sum scores. Factors associated with the level of knowledge of late AEs were analyzed by linear regression analysis. <b>Results:</b> Eighty-one percent of the survivors knew their diagnosis, 99% knew the components of HD-ASCT and 97% correctly recalled having had radiotherapy. Ninety percent reported awareness of late AEs, but the level of knowledge and personal experience with specified AEs varied. Thirty-five percent of survivors stated to have received follow-up for late AEs. In multivariable analysis younger age at diagnosis, having received mediastinal radiotherapy, higher mental health related quality of life, a higher number of self-experienced late AEs and having received follow-up care for late AEs were significantly associated with a higher level of knowledge of AEs. <b>Conclusion:</b> The majority of lymphoma survivors treated with HD-ASCT correctly recalled diagnosis and treatment, while knowledge of late AEs varied. Our findings point to information deficits in survivors at older age and with lower mental health related quality of life. They indicate benefit of follow-up to enhance education on late AEs in lymphoma survivors.
DOI: 10.6084/m9.figshare.8845193.v1
title: Survivors’ knowledge of their diagnosis, treatment and possible late adverse effects after autologous stem cell transplantation for lymphoma

description: <b>Purpose:</b> Lymphoma survivors after high dose therapy with autologous stem cell therapy (HD-ASCT) are at high risk for late adverse effects (AEs). Information patients receive and collect throughout their cancer trajectory about diagnosis, treatment schedule and risks of AEs may influence attitudes and health-related behavior in the years after treatment. The purpose of this study was to explore level of knowledge in lymphoma survivors after HD-ASCT at a median of 12 years after primary diagnosis. <b>Material and methods:</b> From a national study on the effects of HD-ASCT for lymphomas, 269 survivors met for an outpatient examination, including a structured interview addressing knowledge about diagnosis and treatment. Survivors were also asked whether they knew and/or had experienced certain common late AEs. Numbers of recognized and experienced late AEs were presented as sum scores. Factors associated with the level of knowledge of late AEs were analyzed by linear regression analysis. <b>Results:</b> Eighty-one percent of the survivors knew their diagnosis, 99% knew the components of HD-ASCT and 97% correctly recalled having had radiotherapy. Ninety percent reported awareness of late AEs, but the level of knowledge and personal experience with specified AEs varied. Thirty-five percent of survivors stated to have received follow-up for late AEs. In multivariable analysis younger age at diagnosis, having received mediastinal radiotherapy, higher mental health related quality of life, a higher number of self-experienced late AEs and having received follow-up care for late AEs were significantly associated with a higher level of knowledge of AEs. <b>Conclusion:</b> The majority of lymphoma survivors treated with HD-ASCT correctly recalled diagnosis and treatment, while knowledge of late AEs varied. Our findings point to information deficits in survivors at older age and with lower mental health related quality of life. They indicate benefit of follow-up to enhance education on late AEs in lymphoma survivors.
DOI: 10.6084/m9.figshare.8845178
title: Supplementary Material for: Outpatient Parenteral Antimicrobial Treatment for Non-Cystic Fibrosis Bronchiectasis Exacerbations: A Prospective Multicentre Observational Cohort Study

description: <b><i>Background:</i></b> The recently published guidelines of the Spanish Society of Pulmonology and Thoracic Surgery encourage physicians to use outpatient antimicrobial therapy to treat exacerbations in patients with non-cystic fibrosis bronchiectasis (NCFB). The published literature on this topic, however, is scarce. <b><i>Methods:</i></b> We report a prospective observational cohort study of patients with NCFB who received treatment at home for at least one exacerbation episode between September 2012 and September 2017 as part of an outpatient parenteral antimicrobial therapy (OPAT) program. Patients were included in the analysis if they fulfilled all of the following criteria: established diagnosis of bronchiectasis according to current guidelines criteria, clinical exacerbation, requiring intravenous antibiotics because of failure to respond to oral antibiotics, or isolation of a microorganism resistant to oral options. <b><i>Objectives:</i></b> To evaluate the effectiveness and safety of the treatment of patients with NCFB exacerbations in an OPAT program under “real-world” conditions. <b><i>Results:</i></b> Sixty-seven patients were treated in the OPAT program due to bacterial exacerbations of NCFB. Forty-five (67.2%) patients were admitted to hospital for a median of 7 days before starting OPAT. Sixty-three (94%) patients achieved resolution of the exacerbation at the end of therapy. Four patients needed hospital readmission, and one died. The OPAT program saved 11,586 days of hospital admission, equivalent to EUR 7,866,904. <b><i>Conclusions:</i></b> OPAT appears to be a safe, effective, and efficient strategy for treating patients with exacerbations of NCFB.
DOI: 10.6084/m9.figshare.8845178.v1
title: Supplementary Material for: Outpatient Parenteral Antimicrobial Treatment for Non-Cystic Fibrosis Bronchiectasis Exacerbations: A Prospective Multicentre Observational Cohort Study

description: <b><i>Background:</i></b> The recently published guidelines of the Spanish Society of Pulmonology and Thoracic Surgery encourage physicians to use outpatient antimicrobial therapy to treat exacerbations in patients with non-cystic fibrosis bronchiectasis (NCFB). The published literature on this topic, however, is scarce. <b><i>Methods:</i></b> We report a prospective observational cohort study of patients with NCFB who received treatment at home for at least one exacerbation episode between September 2012 and September 2017 as part of an outpatient parenteral antimicrobial therapy (OPAT) program. Patients were included in the analysis if they fulfilled all of the following criteria: established diagnosis of bronchiectasis according to current guidelines criteria, clinical exacerbation, requiring intravenous antibiotics because of failure to respond to oral antibiotics, or isolation of a microorganism resistant to oral options. <b><i>Objectives:</i></b> To evaluate the effectiveness and safety of the treatment of patients with NCFB exacerbations in an OPAT program under “real-world” conditions. <b><i>Results:</i></b> Sixty-seven patients were treated in the OPAT program due to bacterial exacerbations of NCFB. Forty-five (67.2%) patients were admitted to hospital for a median of 7 days before starting OPAT. Sixty-three (94%) patients achieved resolution of the exacerbation at the end of therapy. Four patients needed hospital readmission, and one died. The OPAT program saved 11,586 days of hospital admission, equivalent to EUR 7,866,904. <b><i>Conclusions:</i></b> OPAT appears to be a safe, effective, and efficient strategy for treating patients with exacerbations of NCFB.
DOI: 10.6084/m9.figshare.8845106
title: PD-L1 and CD47 scoring

description: Table quantifying the % and intensity of PD-L1 and CD47 in a subset of patients with adenocarcinoma and squamous cell carcinoma<br>
DOI: 10.6084/m9.figshare.8845103
title: Supplemental Figure Legends

description: Word document describing legends to supplemental Figures and videos<br>
DOI: 10.6084/m9.figshare.8845106.v1
title: PD-L1 and CD47 scoring

description: Table quantifying the % and intensity of PD-L1 and CD47 in a subset of patients with adenocarcinoma and squamous cell carcinoma<br>
DOI: 10.6084/m9.figshare.8845103.v1
title: Supplemental Figure Legends

description: Word document describing legends to supplemental Figures and videos<br>
DOI: 10.6084/m9.figshare.8845100
title: Gene database for Bacillus subtilis 168

description: Information on gene name and gene sequence are particularly useful for molecular cloning, genome editing and phylogenetic analysis. Hence, a database of gene name and gene sequence of a particular microbial species would be a very useful tool for researchers in metabolic engineering, synthetic biology and molecular phylogeny. In this contribution, an in-house MATLAB software was used to parse annotated genome information of <i>Bacillus subtilis </i>168 from Genbank. Gene names and gene sequence retrieved were catalogued into a database that was output into an Excel file for ease of access and retrieval. Overall, the database of gene names and gene sequence of <i>B. subtilis</i> 168 should serve as a useful resource in many areas of fundamental and applied microbiology.<br>
DOI: 10.6084/m9.figshare.12805061
title: supplimentary.xlsx

description: This data is related to the paper submitted to "Journal of Sustainable Energy" named "<b>Carbon Dioxide Pipeline Route Optimization for Carbon Capture, Utilization, and Storage: A case study for North-Central USA"</b>
DOI: 10.6084/m9.figshare.12805061.v2
title: supplimentary.xlsx

description: This data is related to the paper submitted to "Journal of Sustainable Energy" named "<b>Carbon Dioxide Pipeline Route Optimization for Carbon Capture, Utilization, and Storage: A case study for North-Central USA"</b>
DOI: 10.6084/m9.figshare.12805061.v1
title: supplimentary.xlsx

description: This data is related to the paper submitted to "Journal of Sustainable Energy" named "<b>Carbon Dioxide Pipeline Route Optimization for Carbon Capture, Utilization, and Storage: A case study for North-Central USA"</b>
DOI: 10.6084/m9.figshare.8841380
title: Additional file 3: of Deletion of Tet proteins results in quantitative disparities during ESC differentiation partially attributable to alterations in gene expression

description: Table S3. RRBS DMRs. (XLSX 3901 kb)
DOI: 10.6084/m9.figshare.8841359
title: Additional file 2: of Deletion of Tet proteins results in quantitative disparities during ESC differentiation partially attributable to alterations in gene expression

description: Table S2. RNA-seq readcounts at D0 and D6 for all samples. (XLSX 3202 kb)
DOI: 10.6084/m9.figshare.8841380.v1
title: Additional file 3: of Deletion of Tet proteins results in quantitative disparities during ESC differentiation partially attributable to alterations in gene expression

description: Table S3. RRBS DMRs. (XLSX 3901 kb)
DOI: 10.6084/m9.figshare.8841359.v1
title: Additional file 2: of Deletion of Tet proteins results in quantitative disparities during ESC differentiation partially attributable to alterations in gene expression

description: Table S2. RNA-seq readcounts at D0 and D6 for all samples. (XLSX 3202 kb)
DOI: 10.6084/m9.figshare.8841353
title: Additional file 2 of On the utilization of deep and ensemble learning to detect milk adulteration

description: A dataset containing nearly 1000 readings from milk samples in the CSV format. FTIR component features and spectral data points are provided for each sample. (CSV 9075 kb)
DOI: 10.6084/m9.figshare.8841344
title: Additional file 1: of Deletion of Tet proteins results in quantitative disparities during ESC differentiation partially attributable to alterations in gene expression

description: Table S1. Primers and gRNAs. (XLSX 13 kb)
DOI: 10.6084/m9.figshare.8841344.v1
title: Additional file 1: of Deletion of Tet proteins results in quantitative disparities during ESC differentiation partially attributable to alterations in gene expression

description: Table S1. Primers and gRNAs. (XLSX 13 kb)
DOI: 10.6084/m9.figshare.8841209
title: Additional file 9: of Integrative analysis of vascular endothelial cell genomic features identifies AIDA as a coronary artery disease candidate gene

description: Transcription factor (TF) binding motifs located in ATACseq peaks that overlap with SNPs associated with coronary artery disease (CAD) or blood pressure (BP). (XLSX 61 kb)
DOI: 10.6084/m9.figshare.8841197
title: Additional file 8: of Integrative analysis of vascular endothelial cell genomic features identifies AIDA as a coronary artery disease candidate gene

description: Enrichment of coronary artery disease (CAD)- and blood pressure (BP)-associated SNPs (or their linkage disequilibrium proxies) in teloHAEC ATACseq or H3K27ac ChIPseq peaks. (XLSX 10 kb)
DOI: 10.6084/m9.figshare.8841209.v1
title: Additional file 9: of Integrative analysis of vascular endothelial cell genomic features identifies AIDA as a coronary artery disease candidate gene

description: Transcription factor (TF) binding motifs located in ATACseq peaks that overlap with SNPs associated with coronary artery disease (CAD) or blood pressure (BP). (XLSX 61 kb)
DOI: 10.6084/m9.figshare.8841197.v1
title: Additional file 8: of Integrative analysis of vascular endothelial cell genomic features identifies AIDA as a coronary artery disease candidate gene

description: Enrichment of coronary artery disease (CAD)- and blood pressure (BP)-associated SNPs (or their linkage disequilibrium proxies) in teloHAEC ATACseq or H3K27ac ChIPseq peaks. (XLSX 10 kb)
DOI: 10.6084/m9.figshare.8841179
title: Additional file 7: of Integrative analysis of vascular endothelial cell genomic features identifies AIDA as a coronary artery disease candidate gene

description: Biological pathways that are enriched for transcription factors that bind within ATACseq peaks profiled in NT and TNFα treated teloHAEC. (XLSX 14 kb)
DOI: 10.6084/m9.figshare.8841179.v1
title: Additional file 7: of Integrative analysis of vascular endothelial cell genomic features identifies AIDA as a coronary artery disease candidate gene

description: Biological pathways that are enriched for transcription factors that bind within ATACseq peaks profiled in NT and TNFα treated teloHAEC. (XLSX 14 kb)
DOI: 10.6084/m9.figshare.8841170
title: Additional file 6: of Integrative analysis of vascular endothelial cell genomic features identifies AIDA as a coronary artery disease candidate gene

description: Transcription factor binding motifs that are represented in ATACseq peaks profiled in NT or TNFα-treated teloHAEC. (XLSX 16 kb)
DOI: 10.6084/m9.figshare.8841170.v1
title: Additional file 6: of Integrative analysis of vascular endothelial cell genomic features identifies AIDA as a coronary artery disease candidate gene

description: Transcription factor binding motifs that are represented in ATACseq peaks profiled in NT or TNFα-treated teloHAEC. (XLSX 16 kb)
DOI: 10.6084/m9.figshare.8841134
title: Additional file 4: of Integrative analysis of vascular endothelial cell genomic features identifies AIDA as a coronary artery disease candidate gene

description: ATAC-sequencing results of teloHAEC NT or treated with TNFα for 4 or 24 h. (XLSX 381 kb)
DOI: 10.6084/m9.figshare.8841134.v1
title: Additional file 4: of Integrative analysis of vascular endothelial cell genomic features identifies AIDA as a coronary artery disease candidate gene

description: ATAC-sequencing results of teloHAEC NT or treated with TNFα for 4 or 24 h. (XLSX 381 kb)
DOI: 10.6084/m9.figshare.8841116
title: Additional file 3: of Integrative analysis of vascular endothelial cell genomic features identifies AIDA as a coronary artery disease candidate gene

description: Biological pathways enriched for genes that are differentially expressed in teloHAEC upon TNFα treatment. (XLSX 14 kb)
DOI: 10.6084/m9.figshare.8841095
title: Additional file 2: of Integrative analysis of vascular endothelial cell genomic features identifies AIDA as a coronary artery disease candidate gene

description: RNA-sequencing results of teloHAEC NT or treated with TNFalpha for 4 or 24 h. (XLSX 216 kb)
DOI: 10.6084/m9.figshare.8841116.v1
title: Additional file 3: of Integrative analysis of vascular endothelial cell genomic features identifies AIDA as a coronary artery disease candidate gene

description: Biological pathways enriched for genes that are differentially expressed in teloHAEC upon TNFα treatment. (XLSX 14 kb)
DOI: 10.6084/m9.figshare.8841095.v1
title: Additional file 2: of Integrative analysis of vascular endothelial cell genomic features identifies AIDA as a coronary artery disease candidate gene

description: RNA-sequencing results of teloHAEC NT or treated with TNFalpha for 4 or 24 h. (XLSX 216 kb)
DOI: 10.6084/m9.figshare.8841026
title: Additional file 16: of Integrative analysis of vascular endothelial cell genomic features identifies AIDA as a coronary artery disease candidate gene

description: Primers used to generate indels in teloHAEC. (XLSX 8 kb)
DOI: 10.6084/m9.figshare.8841014
title: Additional file 15: of Integrative analysis of vascular endothelial cell genomic features identifies AIDA as a coronary artery disease candidate gene

description: Primers sequences for quantitative PCR. (XLSX 10 kb)
DOI: 10.6084/m9.figshare.8841026.v1
title: Additional file 16: of Integrative analysis of vascular endothelial cell genomic features identifies AIDA as a coronary artery disease candidate gene

description: Primers used to generate indels in teloHAEC. (XLSX 8 kb)